Citations for
1NUDCD1
A novel mechanism of alternative promoter and splicing regulates the epitope generation of tumor antigen CML66-L.
Yan Y, Phan L, Yang F, Talpaz M, Yang Y, Xiong Z, Ng B, Timchenko NA, Wu CJ, Ritz J, Wang H, Yang XF.
J Immunol 172(1):651-60. 2004
2NUDCD1
CML66, a broadly immunogenic tumor antigen, elicits a humoral immune response associated with remission of chronic myelogenous leukemia.
Yang XF, Wu CJ, McLaughlin S, Chillemi A, Wang KS, Canning C, Alyea EP,Kantoff P, Soiffer RJ, Dranoff G, Ritz J.
Proc Natl Acad Sci U S A 98(13):7492-7. 2001